Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis.

Our meta-analysis suggests that IGB therapy is associated with improvements in insulin resistance, blood pressure, and dyslipidemia at 6 months. The results of this analysis suggest that IGB placement can be a viable treatment option to improve important metabolic parameters beyond weight loss alone.